Real-time, Inline, On Site

Large quantities of environmentally harmful chemicals are generally required to purify active ingredients produced by bio-process based routes.

MyBiotech GmbH has developed an innovative continuous end-to-end process which reduces the carbon footprint and the environmental impact of rapamycin production assessed by the toxicity of the process chemistry and products.

With the basic process steps established, work towards a fully integrated process demonstration is underway, with further optimization being carried out to maximize the process efficiency and scale-up towards commercialization.

Find out more in this accessible two-page industrial case study arising from the ETERNAL Horizon Europe Research and Innovation Action.

Download case study now